Tests in

Fabry Disease

View Test

Factor V (Leiden) Mutation (R506Q)

  • Test Code:
    1420
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Factor V Leiden • Hereditary Resistance Activated Protein C Resistance • Resistance to Activated Protein C • Activated protein C resistance • APC resistance • Factor V R506Q • FCV
View Test

Familial Aneurysm and Aortopathy

  • Test Code:
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Thoracic Aortic Aneurysms and Aortic Dissections (TAAD) • Marfan Syndrome • Loeys-Dietz Syndrome (LDS) • Ehlers-Danlos Syndrome • Shprintzen-Goldberg Syndrome • Connective Tissue Disorders • ACTA2 • ADAMTS2 • B3GALT6 • B4GALT7 • CBS • CHST14 • COL1A1 • COL1A2 • COL3A1 • COL5A1 • COL5A2 • FBN1 • FBN2 • FKBP14 • FLNA • MED12 • MYH11 • MYLK • NOTCH1 • PLOD1 • PRDM5 • SKI • SLC2A10 • SLC39A13 • SMAD3 • TGFB2 • TGFB3 • TGFBR1 • TGFBR2 • TNXB • ZNF469
View Test

Fanconi Anemia FISH Panel

View Test

Fanconi Anemia Panel

  • Test Code:
    1460
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Fanconi Anemia sequencing panel • Fanconi Anemia NGS • FANCA • FANCB • FANCC • FANCD1/BRCA2 • FANCD2 • FANCE • FANCF • FANCG • FANCI • FANCJ/BRIP1 • FANCL • FANCM • FANCN/PALB2 • FANCO/RAD51C • FANCP/SLX4 • BLM • RAD51
View Test

Fatty Acid Hydroxylase-Associated Neurodegeneration (FAHN), FA2H, Sequencing

View Test

Fatty Acid Oxidation Deficiency Panel

  • Test Code:
  • Department:
    Molecular Genetics
  • Test Synonyms:
    ACAD9 • ACADL • ACADM • ACADS • ACADVL • CPT1A • CPT1B • CPT2 • ETFA • ETFB • ETFDH • GLUD1 • HADH • HADHA • HADHB • HMGCL • HMGCS2 • HSD17B10 • LPIN1 • SLC22A5 • SLC25A20 • TAZ
View Test

FGFR1 FISH

  • Test Code:
    8218
  • Department:
    Cancer FISH
  • Test Synonyms:
    FGFR1 FISH • fibroblast growth factor receptor 1 FISH
View Test

FISH Library - Constitutional

  • Test Code:
    7300
  • Department:
    Constitutional FISH
  • Test Synonyms:
    AneuVysion (chromosomes 13, 18, 21, X and Y) • Angelman Syndrome (SNRPN/D15S10) (15q11-13) • CEP X and CEP Y • Cri-du-chat (5p-) Syndrome (5p15.2) • DiGeorge Syndrome (DGS) (TUPLE1) (22q11.2) • Kallman Syndrome (KAL) (Xp22.3) • Miller-Dieker Syndrome (LIS1) (17p13.3) • Prader-Willi Syndrome (SNRPN/D15S10) (15q11-13) • SHOX-related haploinsufficiency disorders (SHOX) (Xp22.33) • Smith-Magenis Syndrome (SMS) (17p11.2) • SNRPN Dup(15) in autism • SRY-related disorders of sex development (SRY) (Yp11.3) • Steroid Sulfatase (STS) (Xp22.3) • Velocardiofacial Syndrome (VCFS) (TUPLE1) (22q11.2) • Williams Syndrome (ELN) (7q11.23) • Wolf-Hirshhorn (4p-) Syndrome (WHS) (4p16.3)
View Test

FISH Library - Oncology

  • Test Code:
    7400
  • Department:
    Cancer FISH
  • Test Synonyms:
    B-ALL • T-ALL • AML • AML+MDS • CLL • DLBCL • FA • Glioma • HES/CMML/MPD • MDS • MM • MZL • NSCLC • 1p36/1q25 • 19p13/19q13 • 4/10/17 ALL • 5p15/15q22 MM • 3 centromere • 8 centromere • 12 centromere • ABL1 break-apart • ABL2 break-apart • AFF1 break-apart • ALK break-apart • ATM • BCL2 break-apart • BCL3 break-apart • BCL6 break-apart • BCR/ABL+/- ASS t(9;22) • BIRC3(API2)/MALT1 t(11;18) • BRAF • CBFB/MYH11 inv(16) • CCND1 break-apart • CDKN2A (p16) • CHIC2/FIPIL1/PDGFRA • CHOP (DDIT3) break-apart • CKS1B/CDKN2C MM • C-MET • C-MYC • COL1A1/PDGFB (DFSP) t(17;22) • CRLF2 break-apart • D13S319/13q34 • D20S108 • D7S486 • DEK/NUP214 t(6;9) • E2A break-apart • E2A/PBX1 t(1;19) • EGFR • EGR1 • ETV6 (TEL) break-apart • ETV6/RUNX1 (TEL/AML) t(12;21) • EVI1 break-apart • EWSR1 break-apart • FGFR1 • FGFR1 break-apart • FOXO1 (FKHR) break-apart • FUS break-apart • HER-2/neu (ERBB2) • IGH break-apart • IGH/BCL2 t(14;18) • IGH/CCND1 t(11;14) • IGH/CCND3 t(6;14) • IGH/FGFR3 t(4;14) • IGH/MAF t(14;16) • IGH/MAFB t(14;20) • IGH/MALT1 t(14;18) • IGH/MYC t(8;14) • IGK break-apart • IGL break-apart • IL3 break-apart • JAK2 break-apart • MALT1 break-apart • MDM2 • MECOM/GATA • MLL (KMT2A) break-apart • MLL/MLLT1 t(11;19) • MLLT3/MLL t(9;11) • MYB/6q21 • MYC break-apart • N-MYC • NUP98 break-apart • PDGFRB break-apart • PML/RARA t(15;17) • PTEN • RARA break-apart • RB1/D13S319/LAMP1 • RET break-apart • ROS1 break-apart • RUNX1 break-apart • RUNX1T1/RUNX1 (ETO/AML) t(8;21) • SS18 (SYT) break-apart • TCL1 break-apart • TP53 (p53) • TRAD (TCR) break-apart • X&Y post-transplant
View Test
Innovations in Testing
View All Tests

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More